Company news

Bruker Corporation news in 2026

Bruker Corporation's news releases, calls and decks from 2026, newest first.

View company

Bruker Reports Third Quarter 2026 Financial Results

November 4, 2026

Bruker Announces Date and Time of Third Quarter 2026 Earnings Release and Webcast

October 20, 2026

Untargeted timsTOF Mass Spectrometry Enables Discovery and Mapping of Draft Atlas of the Human Plasma Proteome at Proteoform Resolution

October 6, 2026

Bruker Advances Functional Proteomics with Novel timsUltra AIP and timsOmni Workflows for Drug Discovery & Development and Disease Biology Research

September 28, 2026

Bruker Receives Order for High-Field NMR Systems for Major Upgrade of Magnetic Resonance Research Infrastructure at UC Berkeley

September 21, 2026

BEST and Luvata Announce Collaboration Agreement for Supply of High-Performance RRP® Superconductors for Magnetic Confinement Fusion

September 4, 2026

Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories

August 11, 2026

Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development

August 10, 2026

Bruker Reports Second Quarter 2026 Financial Results

August 4, 2026

Bruker Announces Date and Time of Second Quarter 2026 Earnings Release and Webcast

July 24, 2026

Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER® Platform for Pathogenic Microorganisms in Blood

July 15, 2026

Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026

June 3, 2026

Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry

June 2, 2026

Bruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis, and Innovations in Hybrid Qual/Quant 4D Metabolomics – all to Enable Deeper Insights into Disease Biology

June 1, 2026

Champalimaud Foundation’s Neuroscience and Oncology Research Benefits from 18 Tesla Ultra-High Field MRI

May 26, 2026

Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q)

May 7, 2026

Opportunity Insights for the $1.1 Billion Preclinical Imaging Industry, 2026 - Bruker Corp., Cubresa, and Siemens Healthineers Lead

May 6, 2026

Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast

April 24, 2026

Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026

April 17, 2026

Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026

April 17, 2026

Bruker Expands Industry-Leading MALDI Biotyper® and IR Biotyper® Workflows for Microbial Identification and Outbreak Management

April 17, 2026

Bruker Unveils New NMR Products and Workflow Solutions at ENC 2026

April 13, 2026

2025 Annual Report of 2025

April 10, 2026

Bruker Invests in Photothermal AFM-IR to Advance Semiconductor Research

April 6, 2026

Bruker Announces Appointment of Thierry Bernard to its Board of Directors

March 31, 2026

PreOmics GmbH and Biognosys AG Prevail in U.S. Patent Challenge

March 30, 2026

Showcases Analytical and Automation Innovations for Applied, Biopharma, Industrial and Academic Markets at Analytica 2026

March 23, 2026

Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XR

February 24, 2026

Bruker Expands Collaboration with Noetik to Advance Tissue Foundational Models for Translational and Therapeutic Applications

February 23, 2026

Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum

February 22, 2026

Bruker Advances Functional Proteomics 2.0 with timsOmniTM Mass Spectrometry Proteoform Analysis for Deeper Insights into Disease Biology

February 22, 2026

Bruker Reports Fourth Quarter and Full Year 2025 Financial Results

February 11, 2026

Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC

February 8, 2026

Bruker Announces Quarterly Preferred Stock Dividend

February 4, 2026

Bruker Announces Date and Time of Fourth Quarter 2025 Earnings Release and Webcast

February 4, 2026

Bruker Announces $500 Million in Multi-Year Orders from Two Global Healthcare Companies for Supply of High-Performance Superconductors for MRI

January 8, 2026

Bruker Consolidates Ownership of TOFWERK in Expansion of Mass Spectrometry Portfolio into New Applied Markets

January 7, 2026

Bruker Corporation to Present at the J.P. Morgan Healthcare Conference

January 7, 2026

Calls in 2026

Decks in 2026